Expression and function of efflux drug transporters in the intestine

被引:266
|
作者
Takano, M [1 ]
Yumoto, R [1 ]
Murakami, T [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Program Pharmaceut Sci, Dept Pharmaceut & Therapeut,Minami Ku, Hiroshima 7348551, Japan
关键词
ABC transporter; P-glycoprotein; multidrug resistance-associated protein 2; breast cancer resistance protein; oral bioavailability; transporter-mediated drug interaction;
D O I
10.1016/j.pharmthera.2005.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of drug transporters expressed in the body control the fate of drugs by affecting absorption, distribution, and elimination processes. In the small intestine, transporters mediate the influx and efflux of endogenous or exogenous substances. In clinical pharmacotherapy, ATP-dependent efflux transporters (ATP-binding cassette [ABC] transporters) expressed on the apical membrane of the intestinal epithelial cells determine oral bioavailability, intestinal efflux clearance, and the site of drug-drug interaction of certain drugs. The expression and functional activity of efflux transporters exhibit marked interindividual variation and are relatively easily modulated by factors such as therapeutic drugs and daily foods and beverages. In this article, we will summarize the recent findings regarding the intestinal efflux transporters, especially P-glycoprotein (P-gp or human multidrug resistance gene [MDR] 1), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:137 / 161
页数:25
相关论文
共 50 条
  • [21] Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport
    Potschka, Heidrun
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (10) : 943 - 952
  • [22] Inhibition of topoisomerase I activity and efflux drug transporters’ expression by xanthohumol from hops
    Sung Ho Lee
    Hyun Jung Kim
    Jung Sun Lee
    Ik-Soo Lee
    Bok Yun Kang
    Archives of Pharmacal Research, 2007, 30 : 1435 - 1439
  • [23] Drug resistance in brain diseases and the role of drug efflux transporters
    Löscher, W
    Potschka, H
    NATURE REVIEWS NEUROSCIENCE, 2005, 6 (08) : 591 - 602
  • [24] Drug resistance in brain diseases and the role of drug efflux transporters
    Wolfgang Löscher
    Heidrun Potschka
    Nature Reviews Neuroscience, 2005, 6 : 591 - 602
  • [25] A Case of Hashimoto's Thyroiditis with Multiple Drug Resistance and High Expression of Efflux Transporters
    Yoshida, Tomohiko
    Nakayama, Akitoshi
    Tamura, Ai
    Higuchi, Seiichiro
    Sakuma, Ikki
    Nagano, Hidekazu
    Felizola, Saulo J. A.
    Hashimoto, Naoko
    Takemoto, Minoru
    Tatsuno, Ichiro
    Koide, Hisashi
    Yokote, Koutaro
    Tanaka, Tomoaki
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02): : 399 - 406
  • [26] DMARDs as substrates for drug efflux transporters: A mechanism for drug resistance?
    Hider, SL
    Hoggard, PG
    Khoo, S
    Back, DJ
    Silman, AJ
    Bruce, IN
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 188 - 188
  • [27] Interplay between drug uptake and efflux transporters in drug disposition
    Kim, RB
    FASEB JOURNAL, 2000, 14 (08): : A1504 - A1504
  • [28] Expression of Efflux Transporters in Human Ocular Tissues
    Chen, Peng
    Chen, Hao
    Zang, Xinjie
    Chen, Min
    Jiang, Haoran
    Han, Shasha
    Wu, Xianggen
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (11) : 1934 - 1948
  • [29] Transporters in the intestine limiting drug and toxin absorption
    Elferink, R. P. J. Oude
    de Waart, R.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2007, 63 (01) : 75 - 81
  • [30] Transporters in the intestine limiting drug and toxin absorption
    R. P. J. Oude Elferink
    R. de Waart
    Journal of Physiology and Biochemistry, 2007, 63 : 75 - 81